CD93 and cancer: Furthermore, in multiple cancer types, CD93 expression positively correlates with the expression of various immune checkpoint molecules, including CD86, leukocyte-associated immunoglobulin-like receptor 1 (LAIR1), V-set immunoregulatory receptor (VSIR), and neuropilin 1 (NRP1).